Test Price
2,200 AED✅ Home Collection Available
Cultured AFB Second-Line Antitubercular Drug Susceptibility Test (DST) Panel in UAE | 2200 AED | 2026 DHA Guidelines
تحليل فحص الحساسية السريع للأدوية المضادة للسل من الخط الثاني (زراعة AFB) في الإمارات | 2200 درهم | 2026 إرشادات هيئة الصحة بدبي
Accuracy Guarantee: 99.9% diagnostic sensitivity for second-line drug resistance via ISO 9001:2015 accredited automated fluorescent methodology (BACTEC MGIT 960).
Premium Logistics: Paid hospital-grade home collection of respiratory specimens (sputum) by VIP mobile phlebotomy, transported under validated cold-chain to our ISO-certified laboratory for pure culture processing.
Clinical Guidance: Complimentary telephonic post‑test interpretation by a DHA‑licensed microbiologist to discuss therapeutic implications.
Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
ملخص تنفيذي: يوفر اختبار فحص الحساسية السريع للأدوية المضادة للسل من الخط الثاني المعتمد من هيئة الصحة بدبي دقة تشخيصية تصل إلى 99.9% وفق معايير ISO، مع خدمة جمع العينات في المنزل ونقلها بسلسلة تبريد معتمدة، وإرشادات طبية هاتفية بعد النتائج.
Overview
The Cultured AFB Second-Line Antitubercular DST Panel determines phenotypic resistance to fluoroquinolones, injectable agents, and other second-line drugs used in multidrug-resistant tuberculosis (MDR-TB). (تحديد مقاومة الأدوية الثانية للسل) Results guide personalised treatment regimens under UAE national TB programme protocols.
| Feature | Our Test (DHA Approved) | Closest Alternative |
|---|---|---|
| Precision | Automated Fluorescent MGIT 960 – quantitative MIC interpretation | Conventional LJ proportion method – subjective colony counting |
| Turnaround Time | 21 days from pure culture | 4‑6 weeks |
| Drug Panel | 10 second-line drugs (amikacin, kanamycin, capreomycin, ofloxacin, levofloxacin, moxifloxacin, ethionamide, linezolid, clofazimine, bedaquiline) | Often limited to 5 drugs |
| Accreditation | ISO 9001:2015 (INT/EGQ/2509DA/3139), DHA-MOHAP aligned | Variable quality systems |
Physician Insight & Safety Protocol
Dr. PRABHAKAR REDDY, DHA Lic. 61713011: “This test is critical for confirming high‑level resistance to core second‑line agents, but it must be interpreted alongside the patient’s clinical history, imaging, and treatment adherence. No single phenotypic result replaces an experienced clinician’s judgment. False‑susceptible results can occur in mixed infections; always request repeat testing if treatment fails.”
⚠️ Medication Warning
Do not discontinue prescribed antitubercular or any concomitant medication without consulting your treating physician. Abrupt cessation may lead to drug‑resistant relapse or life‑threatening deterioration.
Exclusion Criteria & Emergency Red Flags
- Pediatric Minors: Home collection for children under 18 must comply with UAE CDS Law 2026 – a legal guardian must provide written informed consent and be present throughout.
- Active Hemoptysis: Clients with coughing up blood >100 mL in 24 hours or severe respiratory distress are excluded from home phlebotomy; immediate ER visit is advised.
- Immunocompromised Hosts: Patients on biologic agents or with CD4 <200 must coordinate testing through their specialist to avoid misclassification.
- ER Red Flags: Sudden chest pain, high fever with rigors, confusion, or oxygen saturation <90% require urgent hospital evaluation, not laboratory scheduling.
Patient FAQ & Clinical Guidance
What does a “rapid second‑line DST” actually detect?
This test identifies phenotypic resistance to ten crucial second‑line antitubercular drugs within a 21‑day window. The pure Mycobacterium tuberculosis isolate is exposed to standardized drug concentrations in a liquid culture system, and growth inhibition is measured automatically by fluorescence. A resistant report means the bactericidal concentration needed exceeds therapeutic safety, so that drug cannot be used effectively in your regimen.
Can I do this test at home, and is a sputum sample enough?
Our VIP phlebotomy team can collect your respiratory specimen at home using strict infection control measures. You will be guided to produce a deep, early‑morning sputum sample into a sterile container; the sample is immediately refrigerated and transported in a validated cold chain to the lab. The laboratory will first culture the bacteria and then perform the DST on pure growth. No fasting or special preparation is needed.
ما سبب احتياج الطبيب لنتائج فحص الحساسية السريع من الخط الثاني بدلاً من الفحص الجيني فقط؟
الفحص الجيني يكشف الطفرات المعروفة فقط، بينما الاختبار الظاهري (الزرعة) يظهر المقاومة الحقيقية بدقة 99.9%. بعض المقاومة تنتج عن آليات لم تُكتشف بعد، لذا يظل فحص الحساسية المبنى على الزرعة المعيار الذهبي لتأكيد فعالية الدواء. هذا التحليل يفيد الأطباء في تفصيل جرعات الجيل الثاني من الأدوية بدقة عند فشل العلاج الأولي.
UAE Regulatory Compliance
This service adheres to Federal Decree‑Law No. 41 of 2024 (Art. 87) on Medical Liability, UAE PDPL for data privacy, and CDS Law 2026 (Minors). Home collection is performed by DHA‑licensed staff under ISO 9001:2015 quality management (Cert: INT/EGQ/2509DA/3139). All results are reviewed by a DHA‑certified microbiologist prior to release.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians